Halberd Corp (PK) (HALB) Börsenkurse

Halberd Corp is a research-based company seeking to develop treatments for a range of diseases. Their extracorporeal method treats blood-borne, neurologic and infectious diseases. Halberd's patents remove bodily fluids in a continuous fashion, like dialysis, or in a batch process. To treat the speci... Halberd Corp is a research-based company seeking to develop treatments for a range of diseases. Their extracorporeal method treats blood-borne, neurologic and infectious diseases. Halberd's patents remove bodily fluids in a continuous fashion, like dialysis, or in a batch process. To treat the specific disease, the treatment is applied to the bodily fluid. Disease eradication via exposure to radio frequency, laser irradiation, or chemical bonding. The cleansed bodily fluids are then returned to the patient without deadly side effects found with injected or ingested medications. Halberds technology base is 4 issued patents and 22 pending patents: Current projects with planned submissions of abstracts to ARPA-H include: * Extracorporeal eradication of inflammatory cytokines from cerebrospinal fluid associated with PTSD and Suicidal Ideation * Therapeutic lozenges to alleviate pain and anxiety as well as chemical and alcohol addiction * Eradication of antibiotic-resistant bacteria and deadly Candida Auris fungi supplied by CDC * Development of a nasal spray is in pre-clinical testing designed to eliminate neurodegenerative cascade associated of head trauma * Extracorporeal eradication of antigens associated with cancer * Extracorporeal eradication of the 10 inflammatory cytokines & the excitatory neurotransmitter associated with Alzheimer's Disease, Parkinson's Disease & Epilepsy * Development of antibodies against Coronavirus & extracorporeal eradication of Covid antigens. Mehr anzeigen